Ciprofloxacin

Ciprofloxacin (Bay-09867) 主要靶点包括细菌的DNA旋转酶 (Gyrase) (IC50=0.22-0.31 µM) 和拓扑异构酶IV (IC50=0.3-1.9 µM)。Ciprofloxacin 是一种有高抗菌活性的氟喹诺酮类抗生素。

Ciprofloxacin monohydrochloride (Bay-09867 hydrochloride) 是一种高抗菌活性的氟喹诺酮类抗生素。

Desethylene ciprofloxacin is a major metabolite of ciprofloxacin . It is also a degradation product of ciprofloxacin that can be created through advanced oxygenation processes as a potential way to remove ciprofloxacin from wastewater. It is also created during degradation of ciprofloxacin by chlorination.

Ciprofloxacin lactate 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T66299，CAS号为 97867-33-9。

Ciprofloxacin-d8 是 Ciprofloxacin 的氘代化合物。Ciprofloxacin 的 CAS 号为 85721-33-1。Ciprofloxacin是一种有高抗菌活性的氟喹诺酮类抗生素。

Ciprofloxacin EP IMpurity A (Fluoroquinolonic Acid) 是一种抗生素和抗菌剂。

Ciprofloxacin hydrochloride monohydrate (Bay-09867 hydrochloride monohydrate) 是一种具有高效抗菌活性的氟喹诺酮类抗生素。

Ciprofloxacin-d8 Hydrochloride 是 Ciprofloxacin Hydrochloride 的氘代化合物。Ciprofloxacin Hydrochloride 的 CAS 号为 93107-08-5。Ciprofloxacin hydrochloride是一种高抗菌活性的氟喹诺酮类抗生素。

Ciprofloxacin (Standard) 是 Ciprofloxacin 的标准品，适用于定量分析、质量控制及生化实验等相关研究。Ciprofloxacin (Bay-09867) 主要靶点包括细菌的DNA旋转酶 (Gyrase) (IC50=0.22-0.31 µM) 和拓扑异构酶IV (IC50=0.3-1.9 µM)。Ciprofloxacin 是一种有高抗菌活性的氟喹诺酮类抗生素。

Ciprofloxacin lactate (Standard) 是 Ciprofloxacin lactate 的标准品，适用于定量分析、质量控制及生化实验等相关研究。Ciprofloxacin lactate 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T66299，CAS号为 97867-33-9。

Ciprofloxacin monohydrochloride (Standard) 是 Ciprofloxacin monohydrochloride 的标准品，适用于定量分析、质量控制及生化实验等相关研究。Ciprofloxacin monohydrochloride (Bay-09867 hydrochloride) 是一种高抗菌活性的氟喹诺酮类抗生素。

Ciprofloxacin-d8 Hydrochloride (Standard) 是 Ciprofloxacin-d8 Hydrochloride 的标准品，适用于定量分析、质量控制及生化实验等相关研究。Ciprofloxacin-d8 Hydrochloride 是 Ciprofloxacin Hydrochloride 的氘代化合物。Ciprofloxacin Hydrochloride 的 CAS 号为 93107-08-5。Ciprofloxacin hydrochloride是一种高抗菌活性的氟喹诺酮类抗生素。

n-acetylciprofloxacin (3-Quinolinecarboxylic acid, 7-(4-acetyl-1-piperazinyl)-1-cyclopropyl-6-fluoro-1) 是 H37Rv 的抑制剂。

Antibacterialagent 254 (Compound 2) 是抗菌剂，可在浓度为 50 μM 的条件下去除 7 天龄的 P. aeruginosa 生物膜，同时不影响细菌的生长。此外，Antibacterialagent 254 还可增强 Ciprofloxacin 对 P. aeruginosa 的杀菌效果，同时提升基质降解酶基因 pelA、pslG 和 eddA 的表达水平。

Antibacterialsynergist 3 是一种双效生物膜 (biofilm) 抑制剂，其在PAO1中的IC50为0.40 μM，在PA14中的IC50为1.45 μM。它通过抑制群体感应 (QS) 系统来减少毒力因子的产生，并引起铜绿假单胞菌 PAO1 的铁缺乏。此外，Antibacterialsynergist 3 能增强小鼠伤口感染模型中Tobramycin和Ciprofloxacin的疗效，适用于研究铜绿假单胞菌感染。

BV600022 is an osteoadsorptive bisphosphonate-ciprofloxacin conjugate with antibacterial activity.

PD 117588 is a quinolone against bacterial isolates from cancer patients. PD 117558 has a broad antimicrobial spectrum with excellent activity against all Gram-positive isolates (including methicillin-resistant Staphylococcus aureus, coagulase-negative st

Ro 24-6392 is an ester-linked co-drug combining ciprofloxacin and desacetylcefotaxime. Ro 24-6392 demonstrats activity against a wide spectrum of aerobic bacteria.

ABT-719 is a 2-pyridinone antimicrobial agent that is more effective against Enterococcus faecalis strains than ciprofloxacin and vancomycin, which showed resistance to ciprofloxacin and vancomycin covering a range of MIC.

IMP-1700 is an inhibitor of bacterial DNA repair.1It potentiates the activity of the quinolone antibiotic ciprofloxacin against methicillin-resistantS. aureus(MRSA) with a combination index value of 0.7. IMP-1700 inhibits the ciprofloxacin-induced bacterial SOS response, a process that repairs DNA damage, in a reporter assay in a concentration-dependent manner. It is also active againstE. coli, as well as methicillin-resistant and -sensitive S. aureus, when used alone (EC50s = 0.5, 0.21, and 3.8 μM, respectively). 1.Lim, C.S.Q., Ha, K.P., Clarke, R.S., et al.Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureusBioorg. Med. Chem.27(20)114962(2019)

Antifungal agent 16 的抗菌活性与环丙沙星相当，且抗真菌活性高于氟康唑。

Anticancer agent 67 是环丙沙星类似物，是一种抗癌剂，在 MCF-7 细胞中能够诱导细胞凋亡 (apoptosis) 并增加亚 G1 细胞群。

Piperazine (2HCl) is gamma-aminobutyric acid (GABA) agonists and its major effects appear to be on the central nervous system. Piperazine was the anthelmintic with the greatest number of reports of toxicoses and suspected toxicoses in cats. Piperazine neurotoxicity in cats and dogs usually was manifested by muscle tremors, ataxia, and or behavioral disturbances within 24 hours after estimated daily dose(s) between 20 and 110 mg kg[1]. For di-substituted derivatives, ciprofloxacin was selected and hybrids were synthesized via substitution at piperazinyl-N4. The reaction of piperazinyl-NH of ciprofloxacin with selected drugs resulted in pronounced growth inhibition of standard as well as resistant bacterial strains[2]. The parent piperazine 6 was found to exhibit a reasonable activity toward the HeLa and MDA MB 231 tumor cell lines (IC50= 9.2 and 8.4 μΜ, respectively)[3]. Piperazine adipate (10 mM) causes mortality of A. galli and H. gallinae after a maximum of 30 min exposure, inhibits malate oxidation by 78%, and inhibits aldolase activity in both parasites. Piperazine adipate (10 mM) also inhibits cholinesterase activity by 96% in Ascaridia galli (A. galli) and 93% in Heterakis gallinae (H. gallinae). Piperazine adipate inhibits oxaloacetate reduction by 26% and 55% in A. galli and H. gallinae, resepctively[4].

Anticancer agent 66 是一种抗癌剂。Anticancer agent 66 在 MCF-7 细胞中诱导细胞凋亡 (apoptosis) 并增加亚 G1 细胞群。Anticancer agent 66 是一种环丙沙星类似物。